Holds one active US DMF and 2 valid CEPs for neomycin, filing since 2017. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
EDQM certificate database
FDA, List of Drug Master Files
Holds one active US DMF and 2 valid CEPs for neomycin, filing since 2017. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for neomycin. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.
Holds one active US DMF for neomycin, filing since 2004.
Holds one valid CEP for neomycin, filing since 2020.
Holds one valid CEP for neomycin, filing since 2010.
Registered with DAV (Vietnam) for neomycin. Its GMP is recognised in 2 markets.
Registered with DAV (Vietnam) for neomycin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for neomycin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for neomycin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for neomycin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for neomycin.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for freeFixed-dose combinations containing neomycin. Each page leads with the verified API makers of every component.